GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Dew,, thats true as far as I know. I agree with Vinnie, on the whole clinicians prefer to see some cellular or molecular mechanism backing up their treatment. If this turns out to be true, (the effect on TNF) it will go along way toward cementing the rational for using AT3 in DIC, and raising the possibility AT3 might have a role in other important clinical situations. This could turn out to be a very big paper. Nice find.